Taking the Pulse, A Health Care and Life Sciences Video Podcast | Episode 260: Innovation and Policy in Animal Health with Ron Phillips of the Animal Health Institute
We get AI for work™: Where to Start When Evaluating AI Tools
We get Privacy for work — Episode 12: Managing Competing Priorities: Data Breach Notification Laws and Trade Secrets
No Password Required: Founder of ThreatLocker and the Zero-Trust Revolution
Taking the Pulse, A Health Care and Life Sciences Video Podcast | Episode 259: The Patient Voice in Clinical Trials with Tom Croce of Jazz Pharmaceuticals
Inside LMA’s TWxSW Conference: GEO, AI, Silos, and the Rule of Law - On Record PR
Building the Case: Construction Litigation Essentials
Key Discovery Points: If You’re Planning to Submit GenAI Deepfake Evidence, Make Sure It’s Believable
The LathamTECH Podcast — Transatlantic Crypto Insights: Tokenization
AI Underwriting Uncovered: Risks, Data, and Liability in Insurance – The Good Bot Podcast
The Impact of the 2024 CrowdStrike Incident on Cyber Insurance
Agentic AI is Knocking on your Company’s Door: Are you Prepared to Deploy It?
Cybersecurity Awareness Month 2025: Legal Risks, Data360, and Practical Strategies
Power Struggles: Innovating Around Energy Challenges in U.S./International Data Center Development — Data Centers Series
The Modern Discovery Traps that Are Upending Cases
The New Wave of Web Tracking Litigation: Wiretap Statutes, VPPA Risk, and Consent Strategies — The Consumer Finance Podcast
Are AI Data Centers the New Power Centers?
Podcast - Operationalizing Data Protection: Build Trust, Not Just Compliance
No Password Required: Building Trust at Intel and the Poker Table
On November 20, 2025, the FDA approved Accord’s Osvyrti® and Jubereq® (denosumab-desu), biosimilars of Amgen’s Prolia® / Xgeva® (denosumab). ...more
In Re: Gesture Technology Partners, LLC, Appeal No. 2025-1075 (Fed. Cir. Dec. 1, 2025) - In our Case of the Week, the Federal Circuit affirmed the denial of a motion to terminate ex parte reexamination proceedings on a...more
Whether you are in-house, outside counsel, a solo practitioner, or working alongside any of these teams, you should be aware of the duty to use artificial intelligence (AI) responsibly, ethically, and in compliance with the...more
The Department of Justice (DOJ), via messaging from its leadership, has made clear it will prioritize and pursue aggressive civil False Claims Act (FCA) enforcement against companies that receive federal dollars....more
Non-tech companies continue efforts to count on AI to transform operations and competitiveness. Infrastructure consulting giant AECOM has acquired Consigli, a five-year-old Norwegian artificial intelligence startup, for...more
As businesses prepare for the holiday season and the new year inches closer, now is the time to revisit Indiana and Kentucky’s comprehensive data privacy laws taking effect on January 1, 2026....more
At long last, on November 13, 2025, India’s Ministry of Electronics and Information Technology (MeitY) released the Digital Personal Data Protection Rules (Rules), which operationalize the Digital Personal Data Protection...more
On November 18, 2025, ToolGen, Inc. (“ToolGen”) filed a complaint (“Complaint”) in the District of Massachusetts alleging infringement of its U.S. Patent No. 12,473,559 (“the ’559 patent”) by Vertex Pharmaceuticals and...more
On December 4, 2025, U.S. Patent and Trademark Office (USPTO) Director John Squires issued two memoranda addressing subject matter eligibility and spotlighting an additional pathway to overcome a rejection under 35 U.S.C. §...more
When Royal Cornwall Hospital responded to a routine Freedom of Information request in 2023, they had no idea they were about to expose sensitive staff data to the public. The hospital recently apologized after discovering...more
We’ve all heard the horror stories. A job seeker spends hours tailoring his resume, finally hits “submit,” and within seconds receives a rejection email in his inbox. Clearly, no human could have actually reviewed the...more
The House passed two capital formation bills aimed at easing securities regulations for venture capital funds, and the following day SEC Chair Paul Atkins outlined the Commission’s agenda to revive U.S. capital markets,...more
On November 25, the House Financial Services Committee majority staff published Operation Chokepoint 2.0: Biden’s Debanking of Digital Assets, a detailed account of how, in the Committee’s view, federal prudential regulators...more
On November 25, 2025, Sarepta Therapeutics filed two petitions for inter partes review (“IPR”) challenging Genzyme’s patents relating to the characterization of recombinant adeno-associated virus (rAAV) vector preparations....more
The Federal Circuit recently made ex parte reexamination proceedings more attractive for those accused of patent infringement. The Court’s decision in In re Gesture Technology Partners, LLC, No. 2025-1075 (Fed. Cir. Dec. 1,...more
Lupin Limited announced on December 1 that it received FDA approval for its biosimilar product, ARMLUPEG (pegfilgrastim-unne). ARMLUPEG is approved as a 6 mg/0.6 mL single-dose prefilled syringe presentation, referencing...more
On November 17, 2025, Sandoz and Polpharma announced the U.S. launch of Tyruko® (natalizumab-sztn), the first and only FDA-approved biosimilar to Biogen’s Tysabri® (natalizumab) and the first biosimilar available to treat...more
It’s no secret: the federal procurement system is undergoing major changes. The President’s “Revolutionary FAR Overhaul” is well underway, the Department of War (“DoW”) has recently announced that traditional program...more
When a cyberattack occurs, time is the most valuable asset. Much like law enforcement’s “first 48” hours rule in criminal investigations, the first 72 hours of a cyberattack, often referred to collectively as the “golden...more
Over the past 18 months, Purpose Legal’s advisory team has consulted, perhaps more than any other eDiscovery topic, on AI-powered document review. Those conversations move very quickly to the same question: first and...more
As another significant year in white-collar crime and corporate enforcement in the UK comes to a close, we have summarised the key developments shaping the regulatory and investigations landscape in 2025. Below is a snapshot...more
In complex commercial agreements, parties are often required to use a specified level of “effort” when performing their obligations. But what distinguishes “best efforts,” “commercially reasonable efforts” or “good faith...more
On November 18, 2025, in Duke University v. Sandoz Inc. (No. 24-1078), the U.S. Court of Appeals for the Federal Circuit reversed a District of Colorado judgment and overturned $39 million of damages awarded by a jury,...more
Discovery used to be pretty straightforward. Most of the data legal teams needed lived on email servers or shared drives, making it easy to find and manage. How times have changed. Now, information resides in an...more
Let us say what compliance officers whisper in hallways but rarely commit to writing: Quality control (QC) in financial crime has been the organizationally orphaned stepchild for decades — not the kind that gets sympathy, but...more